The University of the Philippines Manila has recently introduced an innovative treatment for Type 2 diabetes: ampalaya (bitter melon) tablets. Developed by the Institute of Herbal Medicine (IHM) at the National Institutes of Health, this new herbal medication aims to provide a natural alternative for managing blood sugar levels in diabetes patients.
Professor Daisy-Mae Bagaoisan, an IHM research assistant professor, highlighted the urgency for accessible diabetes treatments, especially in countries like the Philippines. “Our ampalaya tablet research presents a natural option that complements current treatments,” she said. Research revealed that powdered ampalaya leaves have shown significant potential in reducing blood sugar, similar to conventional medications.
After clinical trials, the tablets effectively reduced fasting plasma glucose levels within three weeks and decreased glycosylated hemoglobin after twelve weeks. Formulated according to WHO guidelines, the tablets are classified as a scientifically validated herbal medicine by the Philippine FDA, distinguishing them from typical dietary supplements.
The new ampalaya tablets provide a stable and accessible alternative for Type 2 diabetes patients, with a shelf life of over 18 months at room temperature.